RIL
ATXS

Rothschild Investment LLC’s Astria Therapeutics ATXS Stock Holding History

Rothschild Investment LLC’s Portfolio ATXS Stock Details ATXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-115
Closed -$1.5K – 3610
2025
Q4 		$1.5K Hold
115
– – ﹤0.01% 2506
2025
Q3 		$837 Hold
115
– – ﹤0.01% 2657
2025
Q2 		$616 Sell
115
-40
-26% -$194 ﹤0.01% 2668
2025
Q1 		$828 Buy
155
+105
+210% +$735 ﹤0.01% 2437
2024
Q4 		$447 Sell
50
-30
-38% -$319 ﹤0.01% 2577
2024
Q3 		$881 Buy
80
+65
+433% +$723 ﹤0.01% 2258
2024
Q2 		$137 Buy
15
+5
+50% +$49 ﹤0.01% 2607
2024
Q1 		$141 Buy
+10
New +$125 ﹤0.01% 1954

Rothschild Investment LLC's ATXS Position: Q1 2026 in Review

Rothschild Investment LLC sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 115 shares — an estimated $1.5K sold.

Rothschild Investment LLC first reported a position in ATXS in Q1 2024 and held it in 8 quarters. The position peaked at $1.5K in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

  • Rothschild Investment LLC reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Rothschild Investment LLC sold 115 Astria Therapeutics shares in Q1 2026, an estimated $1.5K.
  • Rothschild Investment LLC first reported a position in Astria Therapeutics in Q1 2024 and held it in 8 quarters.
  • Rothschild Investment LLC's Astria Therapeutics position peaked at $1.5K in Q4 2025.
  • 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Rothschild Investment LLC's 13F filing for Q1 2026, filed 7 May 2026.